http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16744010

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Intramural
issn 0392-9078
1756-9966
issueIdentifier 1
pageRange 95-
publicationName Journal of experimental & clinical cancer research : CR
startingPage 95
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_969ccf6fe026f2f48265f62ea5c814c6
bibliographicCitation Jain L, Sissung TM, Danesi R, Kohn EC, Dahut WL, Kummar S, Venzon D, Liewehr D, English BC, Baum CE, Yarchoan R, Giaccone G, Venitz J, Price DK, Figg WD. Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. Journal of Experimental & Clinical Cancer Research. 2010 Jul 14;29(1):95. doi: 10.1186/1756-9966-29-95.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5023-7562
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_095ef29dae7637fae5d7708ae75642c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6303c92b849f8fd5d38948fa9960ac72
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_434988dd9f44167d3a6822d40f680a46
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bf9a6e0183bd779dcfd94e1050d2790
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2e7673258448bd7fd226e7eef238829
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0cacdc5f9e64b58f3c7d0c340a25985
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a909d7b87baf39fb75ad49e540127c2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d07150d350af10d793f0f68f87dfc81
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_199a50761a232dfe7c87fc992856b80e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da40b6ca0299eed249a490c12f72d3ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77615d3b8a440087f593620f1d5b6d74
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dfd7df444e2045087f75096785e9c6c4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_079fc03cbe0c7a94a12450206389e9a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d45f193552c3dbc7e27dfdb7aef20ba0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e72bb4037064353f08ad5ea25d5a6949
date 2010-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/20630084
https://doi.org/10.1186/1756-9966-29-95
https://pubmed.ncbi.nlm.nih.gov/PMC2913951
isPartOf https://portal.issn.org/resource/ISSN/0392-9078
https://portal.issn.org/resource/ISSN/1756-9966
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20601
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib
discusses http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0446095
http://id.nlm.nih.gov/mesh/M0006685
http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0185196
http://id.nlm.nih.gov/mesh/M0002336
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0014833
http://id.nlm.nih.gov/mesh/M0016578
http://id.nlm.nih.gov/mesh/M0443627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb58e6788fc9a69c674bb00f98bffc14
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247499656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127713618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128056944
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83785
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432

Total number of triples: 63.